How has AptarGroup's pharma — foreign currency exchange effects changed year-over-year?

AptarGroup's pharma — foreign currency exchange effects decreased by 142.5% year-over-year, from $10.27M to -$4.36M.

What does pharma — foreign currency exchange effects mean?

Measures the impact of fluctuations in foreign exchange rates on the segment's reported financial results. Because the segment operates globally, changes in currency values relative to the reporting currency can significantly inflate or deflate reported sales and earnings.

AptarGroup (ATR) Pharma — Foreign currency exchange effects

Screener

Other segment segments

Beauty

-$690K—

Closures

-$284K—

Similar metrics at other companies

MTNLodging — Effects of changes in foreign currency exchange rates

$0—

MTNMountain — Effects of changes in foreign currency exchange rates

$27.87M—

PBH

PBHInternational OTC Healthcare — Effects of foreign currency exchange rates

$63K-92.9%

STAutomotive — Foreign currency translation effect

$25K+200%

STIndustrials — Foreign currency translation effect

$0—

EPAMAmericas — Effect of net foreign currency exchange rate changes

-$98K-115%

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$8.69B-4.7%

Enterprise value$9.9B-2.2%

P/E22.5×-0.8×

P/S2.3×-0.3×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:22 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000896622-26-000092

Line item	Pharma	Beauty	Closures	Total
Balance as of December 31, 2025	$538,703	$370,848	$168,347	$1,077,898
Foreign currency exchange effects	(4,364)	(690)	(284)	(5,338)
Balance as of March 31, 2026	$534,339	$370,158	$168,063	$1,072,560

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's pharma — foreign currency exchange effects?: AptarGroup (ATR) reported pharma — foreign currency exchange effects of -$4.36M in Q1 2026.
How has AptarGroup's pharma — foreign currency exchange effects changed year-over-year?: AptarGroup's pharma — foreign currency exchange effects decreased by 142.5% year-over-year, from $10.27M to -$4.36M.
What does pharma — foreign currency exchange effects mean?: Measures the impact of fluctuations in foreign exchange rates on the segment's reported financial results. Because the segment operates globally, changes in currency values relative to the reporting currency can significantly inflate or deflate reported sales and earnings.